NeRRe Therapeutics
Develops clinical and PRE-clinical neurokinin receptor antagonists
NeRRe Therapeutics has raised €14M across 1 funding round from 3 investors, most recently a Series A round in Dec 2012. Based in Hertford, UK; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Hertford, UKFounded 2012
Total raised
€14M
€14,169,105
Funding rounds
1
Investors
3
distinct backers
Active since
2012-12
latest 2012-12
Funding by year
EUR raised per yearNeRRe Therapeutics — funding by year — interactive chart.
Data table
| NeRRe Therapeutics — funding by year | |
|---|---|
| 2012 | €14M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-12-01 | Series A | €14M | Advent Venture Partners,Novo A,S | View deal → |